Clinical Trial: The Use of DPP-4 Inhibitors in Short Bowel Syndrome

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

---

Official Title: The Use of Dipeptidyl Peptidase-4 Inhibitor Influences the Absorption of Intestine in Short Bowel Syndrome

Brief Summary: The inhibition of Dipeptidyl peptidase-4 should increase the concentration of glucagone-like peptide 1 and 2, and the increase of the latter should increase the absorptive capacity of the intestine.